Prostatic Neoplasms: all 6,484 studies
Page 44 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.
- A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate CancerTerminatedNCT02963051Phase 1
- Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a DocetaxelCompletedNCT02961257Phase 3
- Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate CancerActive, not recruitingNCT02960087Not applicable
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyActive, not recruitingNCT02960022Phase 2
- PROstaTe Cancer - Exercise-STudy (PRO-TEST)CompletedNCT02954783Not applicable
- Cooking Class Intervention Project for Men With Prostate Cancer and Their PartnersCompletedNCT02954289Not applicable
- Biodistribution/Reproducibility Ga-68 PSMA-HBED-CCCompletedNCT02952469Early Phase 1
- A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA MutationsStatus unknownNCT02950064Phase 1
- Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate CancerCompletedNCT02946008Phase 1
- SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After ProstatectomyTerminatedNCT02945813Phase 2
- Machine-learning Optimization for Prostate Brachytherapy PlanningCompletedNCT02943824Not applicable
- RADTOX: Measuring Radiation Toxicity Using Circulating DNACompletedNCT02941029
- Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection TechniqueStatus unknownNCT02940977
- Comparison Of DIR-MRI And DCE-MRI In Detection Of Prostate Cancer: A Pilot StudyCompletedNCT02939456Not applicable
- PRostate Evaluation for Clinically Important Disease: MRI vs Standard Evaluation ProceduresStatus unknownNCT02936258Not applicable
- Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniquesStatus unknownNCT02935816
- Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate CancerStatus unknownNCT02935023Phase 2
- Prospective Cohort Study of the Ability of MRI/DTI to Diagnose Prostate CancerStatus unknownNCT02934776Not applicable
- IG-VMAT for Localized Prostate CancerStatus unknownNCT02934685Phase 3
- ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.TerminatedNCT02933801Phase 2
- ClariCore Optical Biopsy System Used in TRUS (Trans-Rectal Ultrasound)-Guided Prostrate BiopsyStatus unknownNCT02928640Not applicable
- SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With AbirateroneCompletedNCT02928432Phase 2
- Taste Acceptability of Tomato-Soy-Arugula Seed Beverages in Men With Prostate CancerCompletedNCT02927899Not applicable
- PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223.Status unknownNCT02925702
- A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)CompletedNCT02924766Phase 1
- PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide.Status unknownNCT02922218
- 68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically TreatedCompletedNCT02920229Not applicable
- Feasibility Study for the Assessment of Sleep Quality in Men With Prostate Cancer Starting ADTCompletedNCT02919904
- HDR Focal: Feasibility StudyActive, not recruitingNCT02918253Not applicable
- Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient OutcomesActive, not recruitingNCT02917798
- Prostatic Artery Embolization Before Radical Prostatectomy in Prostate Cancer: A Proof-of-concept StudyCompletedNCT02917161Not applicable
- A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057CompletedNCT02916537Phase 1
- SPCG17: Prostate Cancer Active Surveillance Trigger TrialActive, not recruitingNCT02914873Not applicable
- Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate CancerStatus unknownNCT02913859Phase 2
- 5 Fractions of Pelvic SABR With Intra Prostatic SABRStatus unknownNCT02911636Not applicable
- Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate CancerTerminatedNCT02911467Phase 1
- Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate CancerCompletedNCT02911350Phase 1
- Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate BiopsyCompletedNCT02909049Phase 4
- Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate CancerCompletedNCT02907372Not applicable
- A Study of the Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate CancerWithdrawnNCT02906605Phase 2
- Palbociclib in Patients With Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT02905318Phase 2
- A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)WithdrawnNCT02905201
- CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceTerminatedNCT02900248
- PSMA PET/CT for Assessment of Recurrent Prostate CancerActive, not recruitingNCT02899312
- Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After RadiationCompletedNCT02899221Not applicable
- Navigant Study- Treatment Patterns in mCRPC (Metastatic Castrate Resistant Prostate Cancer )CompletedNCT02899104
- LDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer PatientsStatus unknownNCT02895854Not applicable
- Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort StudyCompletedNCT02895230
- Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201CompletedNCT02887976Phase 3
- Safety and Efficacy of Firmagon® (Degarelix) for InjectionCompletedNCT02886598
- Utility of Dynamic Variables Measured by Calibrated Pulse Contour Analysis of Oesophageal Doppler Monitor for Predicting Fluid Responsiveness During Robot-Assisted Laparoscopic ProstatectomyTerminatedNCT02886546Not applicable
- Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food IntakeCompletedNCT02883166Phase 1
- Validation of Software-based Fusion of Ultrasound and MRI Images of the ProstateCompletedNCT02882958
- Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate CancerActive, not recruitingNCT02881242Phase 2
- Evaluation of the Accuracy of the Elastic Fusion MRI-ultrasound Obtained in Vivo by the Koelis™ SystemStatus unknownNCT02879851
- Geriatric Determinants of General Repercussion of Radiotherapy for Patient Over 75 Years With Prostate CancerCompletedNCT02876237Not applicable
- Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate CancersCompletedNCT02873117
- Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness EducationCompletedNCT02871752Not applicable
- Computer-Based Behavior Change Guide in Increasing Physical Activity in Patients With Prostate Cancer Who Have Received Androgen Deprivation TherapyCompletedNCT02869412Not applicable
- Circulating And Intra-Tumoral Chemokines In Patients With Prostate CancerWithdrawnNCT02869282
- PD-1 Knockout Engineered T Cells for Castration Resistant Prostate CancerWithdrawnNCT02867345
- Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone LevelsCompletedNCT02867020Phase 2
- Study of SXL01 in Patients With Metastatic Castration-Resistant Prostate Cancer (PROSTIRNA)WithdrawnNCT02866916Phase 1
- Investigating the Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) on the Treatment of Subjects With CRPCWithdrawnNCT02864784Phase 1
- Collaborative Network to Take Responsibility for Oral Anticancer TherapyStatus unknownNCT02861209Not applicable
- WB-DW-MRI vs CHOLINE-PET/CT for Selecting Treatments in Recurrent Prostate CancerCompletedNCT02858128
- Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate CancerCompletedNCT02856100
- Impact on Quality of Life 3 Years After Diagnosis of Prostate CancerCompletedNCT02854982
- Quality of Life of Patients With Locally Advanced and Metastatic Prostate CancerCompletedNCT02853409
- Hypofractionated Focal Lesion Ablative Microboost in prostatE CancerCompletedNCT02853110Phase 2
- Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer PatientsTerminatedNCT02853097
- The Role of C-11 Choline PET in Patients With Prostate CancerCompletedNCT02852122Not applicable
- Visually Enhanced Education About Prostate CancerCompletedNCT02846870Not applicable
- Improved Prostate Cancer Diagnosis - Combination of Rapid Prebiopsy Magnetic Resonance Imaging and BiomarkersStatus unknownNCT02844829Not applicable
- A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate CancerStatus unknownNCT02844699Phase 1/2
- Hyperpolarized Carbon-13 Imaging of Metastatic Prostate CancerTerminatedNCT02844647Phase 1
- ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph NodesStatus unknownNCT02840617Phase 1
- The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate CancerCompletedNCT02840552Phase 3
- Pre-Prostatectomy Celecoxib or PlaceboTerminatedNCT02840162Phase 2
- ADT Exercise Trial and Economic AnalysisCompletedNCT02834416Phase 3
- Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate CancerCompletedNCT02833883Phase 1
- Effect of Intravenous Magnesium During Robot Assisted ProstatectomyCompletedNCT02833038Not applicable
- CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate CancerStatus unknownNCT02831920Not applicable
- Prostate Biopsy Access Needle & Needle Guide Feasibility StudyCompletedNCT02828839Not applicable
- Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate CancerCompletedNCT02826772Phase 1
- C11 Sodium Acetate PET/CT Imaging of PCaNo longer availableNCT02826395
- Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate CancerCompletedNCT02825875
- Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)CompletedNCT02825628Phase 2
- A Prospective Randomized Trial of Two Different Prostate Biopsy SchemesCompletedNCT02825225Not applicable
- Sulphate Accumulation in ProstateCompletedNCT02821728Not applicable
- Preoperative Brimonidine on IOP of Patients Undergoing RALPCompletedNCT02818816Phase 4
- SBRT for Oligometastatic Castration-Refractory Prostate CancerCompletedNCT02816983
- PET-CT/MRI in the Radiotherapy for Prostate CancerStatus unknownNCT02816840Phase 1/2
- Imaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving EnzalutamideCompletedNCT02815033Phase 2
- PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving EnzalutamideCompletedNCT02814968Phase 2
- Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway InhibitorCompletedNCT02814669Phase 1
- A Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer ParticipantsCompletedNCT02813408
- Assessment of New Molecular Imaging Strategies for Prostate CancerCompletedNCT02813226Not applicable
- Postoperative Patient Comfort and Quality of Micturition in Suprapubic Tube vs. Transurethral Catheterization After RARPCompletedNCT02812173Not applicable
- Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate CancerWithdrawnNCT02811809Phase 2